title: Topical metronidazole for rosacea.
abstract: Rosacea is relatively common, typically occurring in individuals of Northern European and Celtic origin between 30 and 50 years of age. It is more common in women, but may be more severe in men. Currently there is no cure available for rosacea, but it can be controlled with topical and oral drug therapy. Topical metronidazole 1% cream is approved by the US FDA for the treatment of inflammatory lesions (papules and pustules) and erythema associated with rosacea. This treatment option is effective, safe and well tolerated.
authors.affiliation: Division of Dermatology, Department of Medicine, Sunnybrook and Women's College Health Sciences (Sunnybrook side), and the University of Toronto, Toronto, Ontario, Canada.
authors.forename: A K
authors.initials: AK
authors.lastname: Gupta
authors.forename: M
authors.initials: M
authors.lastname: Chaudhry
mesh_terms: D000287:Administration, Topical; D002986:Clinical Trials as Topic; D006801:Humans; D008795:Metronidazole / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D012393:Rosacea / Q000188:drug therapy*
chemical_list: D008795:Metronidazole